David Kolb
Overview
Explore the profile of David Kolb including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
101
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Selzer G, Rueden C, Hiner M, Evans E, Kolb D, Wiedenmann M, et al.
Front Bioinform
. 2024 Oct;
4:1435733.
PMID: 39399098
Decades of iteration on scientific imaging hardware and software has yielded an explosion in not only the size, complexity, and heterogeneity of image datasets but also in the tooling used...
2.
Reiberg M, Hitzler L, Apfelbacher L, Schanz J, Kolb D, Riegel H, et al.
Materials (Basel)
. 2022 Nov;
15(22).
PMID: 36431376
High entropy alloys (HEAs) and their closely related variants, called multi-principal element alloys (MPEAs), are the topic of a rather new area of research, and so far, the gathered knowledge...
3.
Kolb D, Kolishetti N, Surnar B, Sarkar S, Guin S, Shah A, et al.
ACS Nano
. 2020 Jul;
14(9):11055-11066.
PMID: 32706241
Cancer cells are known to be glycolytic, driving increased glucose consumption and its conversion to lactate. This process modulates the tumor microenvironment (TME). In the TME, glycolytically activated immune cells...
4.
Dreser N, Madjar K, Holzer A, Kapitza M, Scholz C, Kranaster P, et al.
Arch Toxicol
. 2019 Nov;
94(1):151-171.
PMID: 31712839
The first in vitro tests for developmental toxicity made use of rodent cells. Newer teratology tests, e.g. developed during the ESNATS project, use human cells and measure mechanistic endpoints (such...
5.
Surnar B, Kolishetti N, Basu U, Ahmad A, Goka E, Marples B, et al.
Biochemistry
. 2018 Oct;
57(46):6500-6513.
PMID: 30281285
Cisplatin is a major chemotherapeutic that continues to have a significant impact in the treatment of more than 50% of all cancers. Since its Food and Drug Administration approval in...
6.
Canning P, Hassfurther R, TerHune T, Rogers K, Abbott S, Kolb D
J Dairy Sci
. 2017 Jun;
100(8):6504-6515.
PMID: 28601453
Periparturient dairy cows experience impaired immune function, exhibited as a transient decrease in neutrophil function. This decrease in immune competence is associated with an increase in susceptibility to bacterial infections,...
7.
Ludwig V, Komori T, Kolb D, Martin W, Sandler M, Delbeke D
Mol Imaging Biol
. 2003 Oct;
4(5):359-62.
PMID: 14537111
Objectives: The purpose of this work was done to evaluate the value of including the brain in the field of view of a whole-body 2-deoxy-2-[18F] fluoro-D-glucose positron emission tomography (FDG-PET)...